BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 10803711)

  • 1. The detection of tyrosinase mRNA in the peripheral blood of stage I melanoma patients is not of clinical relevance in predicting metastasis risk and survival.
    Aubin F; Chtourou M; Teyssier JR; Laubriet A; Mougin CH; Blanc D; Humbert P
    Melanoma Res; 2000 Apr; 10(2):113-8. PubMed ID: 10803711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of tyrosinase mRNA from the blood of melanoma patients.
    Stevens GL; Scheer WD; Levine EA
    Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):293-6. PubMed ID: 8722221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of melanoma cells in peripheral blood by reverse transcription-polymerase chain reaction for tyrosinase and MART-1 after mononuclear cell collection with cell preparation tubes: a comparison with the whole blood guanidinium isothiocyanate RNA isolation method.
    de Vries TJ; Fourkour A; Punt CJ; Ruiter DJ; van Muijen GN
    Melanoma Res; 2000 Apr; 10(2):119-26. PubMed ID: 10803712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of melanoma cells in the blood of melanoma patients by melanoma-inhibitory activity (MIA) reverse transcription-PCR.
    Mühlbauer M; Langenbach N; Stolz W; Hein R; Landthaler M; Buettner R; Bosserhoff AK
    Clin Cancer Res; 1999 May; 5(5):1099-105. PubMed ID: 10353744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic role of circulating melanoma cells detected by reverse transcriptase-polymerase chain reaction for tyrosinase mRNA in patients with melanoma.
    Visús C; Andres R; Mayordomo JI; Martinez-Lorenzo MJ; Murillo L; Sáez-Gutiérrez B; Diestre C; Marcos I; Astier P; Godino J; Carapeto-Marquez de Prado FJ; Larrad L; Tres A
    Melanoma Res; 2007 Apr; 17(2):83-9. PubMed ID: 17496783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of peripheral blood and bone marrow tyrosinase messenger RNA in malignant melanoma.
    Ghossein RA; Coit D; Brennan M; Zhang ZF; Wang Y; Bhattacharya S; Houghton A; Rosai J
    Clin Cancer Res; 1998 Feb; 4(2):419-28. PubMed ID: 9516931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reproducibility of detection of tyrosinase and MART-1 transcripts in the peripheral blood of melanoma patients: a quality control study using real-time quantitative RT-PCR.
    de Vries TJ; Fourkour A; Punt CJ; van de Locht LT; Wobbes T; van den Bosch S; de Rooij MJ; Mensink EJ; Ruiter DJ; van Muijen GN
    Br J Cancer; 1999 May; 80(5-6):883-91. PubMed ID: 10360670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of tyrosinase mRNA by an optimised nested RT-PCR in the peripheral blood of patients with advanced malignant melanoma.
    Glumac N; Hocevar M; Snoj M; Novakovic S
    J Exp Clin Cancer Res; 2001 Dec; 20(4):529-36. PubMed ID: 11876547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular test for the detection of tumor cells in blood and sentinel nodes of melanoma patients.
    Van der Velde-Zimmermann D; Roijers JF; Bouwens-Rombouts A; De Weger RA; De Graaf PW; Tilanus MG; Van den Tweel JG
    Am J Pathol; 1996 Sep; 149(3):759-64. PubMed ID: 8780380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis of tyrosinase and tyrosinase-related protein-2 mRNA from melanoma cells in blood by real-time polymerase chain reaction.
    Johansson M; Arstrand K; Håkansson A; Lindholm C; Kågedal B
    Melanoma Res; 2000 Jun; 10(3):213-22. PubMed ID: 10890374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic relevance of baseline and sequential peripheral blood tyrosinase expression in 200 consecutive advanced metastatic melanoma patients.
    Quaglino P; Osella-Abate S; Cappello N; Ortoncelli M; Nardò T; Fierro MT; Cavallo F; Savoia P; Bernengo MG
    Melanoma Res; 2007 Apr; 17(2):75-82. PubMed ID: 17496782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of circulating malignant cells by RT-PCR in long-term clinically disease-free I stage melanoma patients.
    Baldi A; Dragonetti E; Battista T; Groeger AM; Esposito V; Baldi G; Santini D
    Anticancer Res; 2000; 20(5C):3923-8. PubMed ID: 11268478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A meta-analysis of reverse transcriptase-polymerase chain reaction for tyrosinase mRNA as a marker for circulating tumor cells in cutaneous melanoma.
    Tsao H; Nadiminti U; Sober AJ; Bigby M
    Arch Dermatol; 2001 Mar; 137(3):325-30. PubMed ID: 11255333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microphthalmia-associated transcription factor and tyrosinase as markers of melanoma cells in blood of patients with melanoma.
    Samija I; Lukac J; Marić-Brozić J; Kusić Z
    Croat Med J; 2004 Apr; 45(2):142-8. PubMed ID: 15103749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of the tyrosinase mRNA probe to detect circulating melanocytes with reverse transcription and polymerase chain reaction.
    Carrillo E; Marchal JA; Prados J; Melguizo C; Vélez C; Arena N; Alvarez L; Serrano S; Aránega A
    Cell Mol Biol (Noisy-le-grand); 1998 Dec; 44(8):1247-52. PubMed ID: 9874512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour microdissemination and survival in metastatic melanoma.
    Schrader AJ; Probst-Kepper M; Grosse J; Kunter U; Franzke A; Sel S; Atzpodien E; Buer J
    Anticancer Res; 2000; 20(5B):3619-24. PubMed ID: 11131671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of circulating neoplastic cells by reverse transcriptase and polymerase chain reaction in melanoma].
    Tessier MH; Denis MG; Lustenberger P; Dreno B
    Ann Dermatol Venereol; 1997; 124(9):607-11. PubMed ID: 9739921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of tyrosinase mRNA detected by nested RT-PCR in patients with malignant melanoma.
    Glumac N; Snoj M; Hocevar M; Novakovic S
    Neoplasma; 2006; 53(1):9-14. PubMed ID: 16416006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of positive RT-PCR for tyrosinase in peripheral blood of malignant melanoma patients with clinical stage, survival and other risk factors.
    Proebstle TM; Jiang W; Högel J; Keilholz U; Weber L; Voit C
    Br J Cancer; 2000 Jan; 82(1):118-23. PubMed ID: 10638977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of tumor-associated circulating mRNA in patients with disseminated malignant melanoma.
    Rappl G; Hasselmann DO; Rössler M; Ugurel S; Tilgen W; Reinhold U
    Ann N Y Acad Sci; 2001 Sep; 945():189-91. PubMed ID: 11708477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.